A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to describe the single-dose, and multiple dose
pharmacokinetics (PK) of intravenous (IV) tedizolid phosphate, or a single dose oral
suspension of tedizolid phosphate, when administered to pediatric participants, full-term
neonates, and preterm neonates.